Showing results (11-20 of 38) with videos related to
Sort By:
Pageof 4
ALTEX|February 15, 2001
AGAATI/ECVAM Workshop on the Validation of Alternative Methods for the Potency Testing of VaccinesMarlies Halder, Coenraad F. M. Hendriksen, Jean-Marc SpieserVaccine|November 28, 2009
The cAMP assay: a functional in vitro alternative to the in vivo Histamine Sensitization testMarieke E Hoonakker, Nicole Ruiterkamp, Coenraad F M HendriksenLaboratory Animals|June 15, 2026
Recognition of pain and distressRené Remie, Paul Fredric Brain, Coenraad F M Hendriksen, et al.Alternatives to Laboratory Animals : ATLA|June 15, 2007
Effects of the introduction of in vitro assays on the use of experimental animals in pharmacological researchPieter M Verbost, Jan van der Valk, Coenraad F M HendriksenVaccine|June 12, 2002
Reduction of animal use in human vaccine quality control: opportunities and problemsBernard Metz, Coenraad F M Hendriksen, Wim Jiskoot, et al.ALTEX|February 13, 2003
Humane endpoints in the efficacy testing of swine erysipelas vaccinesSigrid Johannes, Joachim Hartinger, Coenraad F M Hendriksen, et al.ALTEX|February 15, 2001
Pertussis Serological Potency Test as an Alternative to the Intracerebral Mouse Protection Test: Development, Evaluation and ValidationArno van Der Ark, Ineke von Straaten-Van De Kappelle, Coenraad F. M. HendriksenRegulatory Toxicology and Pharmacology : RTP|February 14, 2017
The Isolated Chicken Eye test to replace the Draize test in rabbitsMenk K Prinsen, Coenraad F M Hendriksen, Cyrille A M Krul, et al.ALTEX|May 5, 2015
Regulatory acceptance and use of serology for inactivated veterinary rabies vaccinesMarie-Jeanne W A Schiffelers, Bas J Blaauboer, Wieger E Bakker, et al.ALTEX|August 1, 2012
Regulatory acceptance and use of 3R models: a multilevel perspectiveMarie-Jeanne W A Schiffelers, Bas J Blaauboer, Coenraad F M Hendriksen, et al.Pageof 4